Pancreatic Disorders News

Although patients in underrepresented groups present with worse outcomes than white patients, pancreatic cancer trials fail to represent non-white patients, according to a presentation at Digestive Diseases Week.

Lamassu Pharma announced the development of its lead therapeutic compound, RABI-767, may fulfill the unmet clinical need for the treatment of patients with pancreatitis, according to a press release.

The diagnostic yield of pancreatic ductal adenocarcinoma was substantial in high-risk mutation carrier but non-existent in mutation-negative proven familial pancreatic cancer kindreds.

Healio Gastroenterology presents the following reports on the most recent research on COVID-19 is gastrointestinal conditions.

These reports include updates on pancreatic cancer, chronic pancreatitis and pancreatic cysts.

Patients with coexistent acute pancreatitis and SARS-CoV-2 infection had an increased risk for severe acute pancreatitis and worse clinical outcomes, according to study results.

Investigators identified and validated a human blood-metabolome prediction model that distinguished between patients with chronic pancreatitis and healthy individuals.

In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss possible preventions for pancreatic cancer.

In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss the need for better early detection of pancreatic cancer.

In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss the need for increased awareness about pancreatic cancer.